Chaperone Proteins
| Category | Mechanisms |
|---|---|
| Also known as | molecular chaperones, heat shock proteins |
| Last updated | 2026-04-14 |
| Reading time | 4 min read |
| Tags | mechanismproteostasisprotein-biology |
Overview
Molecular chaperones are a diverse set of proteins that help other proteins reach, maintain, or return to their correctly folded state. They do not form part of the final structure of their client proteins but instead act transiently to prevent inappropriate intermolecular interactions during folding, to refold denatured proteins, and to target terminally misfolded ones for degradation. Because nascent polypeptides are vulnerable to aggregation and established proteins face constant stress, chaperones are essential for cellular survival.
Chaperones are often called heat shock proteins (HSPs) because many were first identified as proteins induced by thermal stress. The major families — organized by approximate molecular weight — include Hsp100, Hsp90, Hsp70, Hsp60 (TRiC/CCT in eukaryotes), and the small HSPs. Each family has distinct substrates, ATPase cycles, and co-chaperones, but all share the principle of binding exposed hydrophobic surfaces of non-native proteins to prevent aggregation.
Chaperones also participate in regulated cellular processes beyond general proteostasis. Hsp90 stabilizes many signaling clients (kinases, steroid hormone receptors, transcription factors), making the cell's signaling network dependent on its activity. The chaperone system is increasingly recognized as a node for drug development in cancer, neurodegeneration, and protein misfolding diseases.
Mechanism / Process
-
Recognition. Chaperones recognize exposed hydrophobic surfaces characteristic of non-native proteins. Hsp70 binds short hydrophobic segments; Hsp90 recognizes partially folded intermediates of specific client families; chaperonins like TRiC encapsulate substrates in a folding chamber.
-
ATP-dependent cycling. Most major chaperones use ATP binding and hydrolysis to cycle between high- and low-affinity substrate-binding states. Co-chaperones (Hsp40/J-proteins, Hop, p23) regulate the cycle.
-
Folding assistance. Chaperones provide a protected environment — either through transient binding that prevents aggregation or by encapsulation in chaperonin cavities — that allows substrates to explore folding pathways.
-
Holdase and foldase activities. "Holdase" chaperones (such as small HSPs) bind unfolded substrates to prevent aggregation but do not actively promote folding. "Foldase" chaperones (Hsp70, Hsp90, Hsp60) use energy to actively advance folding.
-
Refolding of stress-denatured proteins. Under heat shock or oxidative stress, chaperones re-fold partially denatured proteins, rescuing them from aggregation.
-
Triage to degradation. When refolding fails, chaperones (with co-chaperones such as CHIP) direct terminally misfolded clients to the ubiquitin-proteasome system or autophagy.
-
Signaling regulation. Hsp90 stabilizes numerous signaling clients, including steroid hormone receptors, kinases, and telomerase. Inhibiting Hsp90 destabilizes these clients with broad therapeutic consequences.
Key Players / Molecular Components
- Hsp70 family. HSPA1 (inducible Hsp70), HSC70 (constitutive), BiP (ER), mortalin (mitochondrial).
- Hsp90 family. HSP90AA1, HSP90AB1 (cytosolic), GRP94 (ER), TRAP1 (mitochondrial).
- Hsp60/TRiC. Chaperonins forming ring-shaped folding chambers.
- Small HSPs. HSP27, alpha-B-crystallin; often oligomeric holdases.
- Co-chaperones. Hsp40/J-proteins (stimulate Hsp70 ATPase), Hop (links Hsp70-Hsp90), p23 (stabilizes Hsp90-client), CHIP (directs to proteasome).
Clinical Relevance / Therapeutic Targeting
Hsp90 inhibitors (geldanamycin derivatives, ganetespib) destabilize kinase and hormone receptor clients and have been studied in cancer. Chaperone-inducing compounds (arimoclomol, HSF1 activators) are explored for ALS, inclusion body myositis, and other proteinopathies. Pharmacological chaperones — small molecules that bind specific misfolded proteins and stabilize native structure — are approved or in trials for lysosomal storage diseases (migalastat for Fabry disease), cystic fibrosis (ivacaftor/lumacaftor), and transthyretin amyloidosis (tafamidis). Chaperone-focused therapies exploit the idea that restoring proteostasis can compensate for mutation-driven instability.
Peptides That Target This Pathway
- Cerebrolysin — studied for neuroprotective effects involving chaperone upregulation.
- Humanin — mitochondrial peptide with chaperone-like cytoprotective actions.
- Selank — investigated for stress-responsive proteostasis effects.
- Semax — proposed modulation of stress-responsive gene expression.
- Thymosin alpha-1 — immunomodulatory peptide with effects on cellular stress responses.
Related Topics
Related entries
- Endoplasmic Reticulum Stress— A cellular state triggered when protein-folding demand in the endoplasmic reticulum exceeds capacity, activating adaptive and apoptotic responses.
- Protein Misfolding— The failure of proteins to attain or maintain their native structure, a common mechanism in neurodegeneration, metabolic disease, and amyloid pathology.
- Ubiquitin-Proteasome System— The ubiquitin-proteasome system is the cell's principal route for selective protein degradation, marking substrates with ubiquitin chains and breaking them down in the 26S proteasome.
- Unfolded Protein Response— The unfolded protein response is an adaptive network of three ER-resident sensors that rebalances protein folding capacity under stress — and commits cells to death if stress is unresolved.